Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report. [electronic resource]
Producer: 20100812Description: 719-20 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- drug therapy
- Adenocarcinoma, Bronchiolo-Alveolar -- drug therapy
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation -- genetics
- Neoplasm Staging
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Pyridines -- therapeutic use
- Sorafenib
- Survival Rate
- Treatment Outcome
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.